Petro Matad funded for its drilling programme which should see production start next year. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Midatech Pharma To Buy Dara BioSciences For Up To USD29.7 Million (ALLISS)

Thu, 4th Jun 2015 06:45

LONDON (Alliance News) - Midatech Pharma PLC said Thursday it will acquire NASDAQ listed oncology supportive care pharmaceutical company DARA BiosSciences Inc for up to USD29.7 million.

It will pay an initial consideration of USD24.0 million through the issue of 5.4 million new shares, based on a Midatech share price of 291 pence, representing around USD1.20 per DARA share. This is a 51% premium over DARA's closing price of USD0.796 per share Wednesday.

Shares in Midatech closed at 293.00 pence Wednesday.

Following completion DARA shareholders would own around 16% of the enlarged company.

Additionally, DARA shareholders will receive one contingent value right per DARA share, which represents a right to additional continent cash payments up to a maximum USD5.7 million based on the performance of some DARA products.

DARA posted a pretax loss of USD9.2 million for 2014 on revenue of USD1.9 million.

The acquisition is expected to close in the second half of 2015.

"The acquisition of DARA provides Midatech with access to an impressive portfolio of products and the potential for a fast-growth revenue stream in our target therapeutic area of oncology. This acquisition also provides us with a commercial footprint in the US, from which we can launch our own products and thus retain more value," said Chief Executive Officer of Midatech Jim Phillips in a statement.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

29 Jun 21 17:10

Midatech raises £10m to continue formulation development

(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £10m before expenses, it announced on Tuesday, to continue its formulation development work.

29 Jun 21 10:53

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

23 Jun 21 16:09

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

17 Jun 21 11:43

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.